Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes.

Luque MA, González N, Márquez L, Acitores A, Redondo A, Morales M, Valverde I, Villanueva-Peñacarrillo ML.

J Endocrinol. 2002 Jun;173(3):465-73.

2.

Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.

Acitores A, González N, Sancho V, Valverde I, Villanueva-Peñacarrillo ML.

J Endocrinol. 2004 Mar;180(3):389-98.

3.

Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.

Alcántara AI, Morales M, Delgado E, López-Delgado MI, Clemente F, Luque MA, Malaisse WJ, Valverde I, Villanueva-Peñacarrillo ML.

Arch Biochem Biophys. 1997 May 1;341(1):1-7.

PMID:
9143346
4.

GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.

Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C.

Am J Physiol. 1998 Sep;275(3 Pt 1):C675-83.

PMID:
9730951
5.

Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats.

López-Delgado MI, Morales M, Villanueva-Peñacarrillo ML, Malaisse WJ, Valverde I.

Endocrinology. 1998 Jun;139(6):2811-7.

PMID:
9607788
6.

Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.

González N, Acitores A, Sancho V, Valverde I, Villanueva-Peñacarrillo ML.

Regul Pept. 2005 Mar 30;126(3):203-11.

PMID:
15664668
7.

Inositolphosphoglycans and diacyglycerol are possible mediators in the glycogenic effect of GLP-1(7-36)amide in BC3H-1 myocytes.

Galera C, Clemente F, Alcantara A, Trapote MA, Perea A, Lopez-Delgado MI, Villanueva-Penacarrillo ML, Valverde I.

Cell Biochem Funct. 1996 Mar;14(1):43-8.

PMID:
8907253
8.

Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats.

Sancho V, Trigo MV, González N, Valverde I, Malaisse WJ, Villanueva-Peñacarrillo ML.

J Mol Endocrinol. 2005 Aug;35(1):27-38.

PMID:
16087719
9.

Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.

Wang L, Guo F, Wei S, Zhao R.

Peptides. 2011 Jun;32(6):1313-9. doi: 10.1016/j.peptides.2011.03.018. Epub 2011 Mar 29.

PMID:
21453734
10.

Characteristics of GLP-1 and exendins action upon glucose transport and metabolism in type 2 diabetic rat skeletal muscle.

Arnés L, González N, Tornero-Esteban P, Sancho V, Acitores A, Valverde I, Delgado E, Villanueva-Peñacarrillo ML.

Int J Mol Med. 2008 Jul;22(1):127-32.

PMID:
18575785
11.

Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.

Ebinger M, Jehle DR, Fussgaenger RD, Fehmann HC, Jehle PM.

Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E88-94.

PMID:
10893327
12.

Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1.

Idris I, Patiag D, Gray S, Donnelly R.

Biochem Pharmacol. 2002 Mar 1;63(5):993-6.

PMID:
11911852
13.

Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver.

Trapote MA, Clemente F, Galera C, Morales M, Alcántara AI, López-Delgado MI, Villanueva-Peñacarrillo ML, Valverde I.

J Endocrinol Invest. 1996 Feb;19(2):114-8.

PMID:
8778163
14.
15.

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.

Baggio LL, Huang Q, Brown TJ, Drucker DJ.

Gastroenterology. 2004 Aug;127(2):546-58.

PMID:
15300587
16.

GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.

Márquez L, González N, Puente J, Valverde L, Villanueva-Peñacarrillo ML.

Diabetes Nutr Metab. 2001 Oct;14(5):239-44.

PMID:
11806463
17.

Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle.

Villanueva-Peñacarrillo ML, Alcántara AI, Clemente F, Delgado E, Valverde I.

Diabetologia. 1994 Nov;37(11):1163-6.

PMID:
7867889
18.

Normalizing action of exendin-4 and GLP-1 in the glucose metabolism of extrapancreatic tissues in insulin-resistant and type 2 diabetic states.

Moreno P, Nuche-Berenguer B, Gutiérrez-Rojas I, Acitores A, Sancho V, Valverde I, González N, Villanueva-Peñacarrillo ML.

J Mol Endocrinol. 2012 Jan 25;48(1):37-47. doi: 10.1530/JME-11-0127. Print 2012 Feb.

PMID:
22065862
19.

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Schirra J, Sturm K, Leicht P, Arnold R, Göke B, Katschinski M.

J Clin Invest. 1998 Apr 1;101(7):1421-30.

20.

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.

Parkes DG, Pittner R, Jodka C, Smith P, Young A.

Metabolism. 2001 May;50(5):583-9.

PMID:
11319721

Supplemental Content

Support Center